XYL vs. IEX, GGG, ROK, IR, DOV, AXON, TS, HUBB, BALL, and FERG
Should you be buying Xylem stock or one of its competitors? The main competitors of Xylem include IDEX (IEX), Graco (GGG), Rockwell Automation (ROK), Ingersoll Rand (IR), Dover (DOV), Axon Enterprise (AXON), Tenaris (TS), Hubbell (HUBB), Ball (BALL), and Ferguson (FERG). These companies are all part of the "industrial products" sector.
IDEX (NYSE:IEX) and Xylem (NYSE:XYL) are both large-cap industrial products companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, community ranking, institutional ownership, valuation and dividends.
IDEX has a net margin of 17.89% compared to IDEX's net margin of 8.27%. Xylem's return on equity of 17.88% beat IDEX's return on equity.
IDEX pays an annual dividend of $2.56 per share and has a dividend yield of 1.1%. Xylem pays an annual dividend of $1.44 per share and has a dividend yield of 1.1%. IDEX pays out 33.7% of its earnings in the form of a dividend. Xylem pays out 52.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. IDEX has increased its dividend for 14 consecutive years and Xylem has increased its dividend for 12 consecutive years. IDEX is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
IDEX has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Comparatively, Xylem has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.
In the previous week, IDEX had 17 more articles in the media than Xylem. MarketBeat recorded 33 mentions for IDEX and 16 mentions for Xylem. IDEX's average media sentiment score of 0.58 beat Xylem's score of 0.31 indicating that Xylem is being referred to more favorably in the news media.
Xylem has higher revenue and earnings than IDEX. IDEX is trading at a lower price-to-earnings ratio than Xylem, indicating that it is currently the more affordable of the two stocks.
IDEX presently has a consensus target price of $241.67, indicating a potential upside of 8.08%. Xylem has a consensus target price of $138.11, indicating a potential upside of 6.51%. Given Xylem's stronger consensus rating and higher possible upside, equities research analysts plainly believe IDEX is more favorable than Xylem.
Xylem received 54 more outperform votes than IDEX when rated by MarketBeat users. Likewise, 62.82% of users gave Xylem an outperform vote while only 58.49% of users gave IDEX an outperform vote.
98.0% of IDEX shares are owned by institutional investors. Comparatively, 88.0% of Xylem shares are owned by institutional investors. 0.5% of IDEX shares are owned by insiders. Comparatively, 0.3% of Xylem shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
IDEX beats Xylem on 13 of the 21 factors compared between the two stocks.
Get Xylem News Delivered to You Automatically
Sign up to receive the latest news and ratings for XYL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding XYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
